Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease by E. Radaelli et al.
Summary. Tumorigenesis in human glioblastoma
multiforme (GBM) is driven by several genetic
abnormalities with disruption of important molecular
pathways, such as p53/MDM2/p14ARF and
EGFR/PTEN/Akt/mTOR. The malignant progression of
human GBM is also primarily associated with a peculiar
multistep pathophysiological process characterized by
intratumoral ischemic necrosis (i.e. pseudopalisading
necrosis) and activation of the hypoxia-inducible factor
(HIF)-1α pathway with consequent peritumoral
microvascular proliferation and infiltrative behaviour.
Predictable preclinical animal models of GBM should
recapitulate the main pathobiological hallmarks of the
human disease. In this study we describe two murine
orthotopic xenograft models using U87MG and U251
human cell lines. Ten Balb/c nude male mice were
orthotopically implanted with either U87MG (5 mice) or
U251 (5 mice) cell lines. Intracranial tumor growth was
monitored through Magnetic Resonance Imaging (MRI).
Immunohistopathological examination of the whole
cranium was performed 30 days after implantation.
U251 orthotopic xenografts recapitulated the salient
pathobiological features described for human GBM,
including invasive behaviour, wide areas of
pseudopalisading necrosis, florid peripheral
angiogenesis, GFAP and vimentin expression,
nonfunctional p53 expression, striking active-caspase-3
and HIF-1α expression along pseudopalisades. U87MG
orthotopic xenografts proved to be very dissimilar from
human GBM, showing expansile growth, occasional
necrotic foci without pseudopalisades, intratumoral
lacunar pattern of angiogenesis, lack of GFAP
expression, fuctional p53 expression and inconsistent
HIF-1α expression. Expression of pAkt was upregulated
in both models. The results obtained suggest that the
U251 orthotopic model may be proposed as a predictive
and reliable tool in preclinical studies since it
recapitulates the most salient pathobiological features
reported for human GBM.
Key words: Glioblastoma multiforme, Hypoxia-
inducible factor-1, Mouse model, Pseudopalisading
necrosis
Introduction
Glioblastoma multiforme (GBM) is the most
common and highest grade primary brain tumor that
generally arises in the cerebral hemispheres (Kleihues et
al., 2000). GBM is divided into those that develop from
astrocytic tumors of lower malignancy grade (secondary
GBM), such as diffuse astrocytomas [World Health
Organization (WHO) grade II] or anaplastic
astrocytomas (WHO grade III), and those that develop
de novo, without evidence of a less malignant precursor
lesion (primary GBM) (Ohgaki and Kleihues, 2007).
Whether arising de novo or from a lower-grade
precursor GBM has a truly dismal prognosis with rapid
clinical progression leading ultimately to death (Mischel
et al., 2003; Brat and Van Meir, 2004). The main
biologic properties that make GBM fatal are poor
response to a series of adjuvant therapies and infiltrative
behaviour that makes complete surgical resection nearly
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impossible (Brat et al., 2004).
Specific genetic abnormalities such as LOH 10q,
TP53 mutation, PTEN mutation, p16INK4a deletion and
EGFR amplification-overexpression are common in
GBM. These genetic aberrations account for a series of
disrupted molecular pathways (i.e. p53/MDM2/p14ARF
pathway; p16INK4a/RB1 pathway; EGFR/PTEN/
Akt/mTOR pathway) that regulate vital cellular
processes, including apoptosis, cell proliferation and cell
migration (Ohgaki and Kleihues, 2007). The
development of GBM is also primarly associated with a
peculiar multistep pathophysiological process that links
intratumoral ischemic necrosis (i.e. pseudopalisading
necrosis) and hypoxia to angiogenesis and infiltrative
behaviour (Brat et al., 2004; Rong et al., 2006).
Pseudopalisading necrosis is basically characterized by
an intratumoral serpentine area of coagulative necrosis
lined by palisade-oriented GBM cells (pseudopalisades)
(Kleihues et al., 2000). Endothelial cell apoptosis in
intratumoral vessels and secondary vascular thrombosis
contribute to the ischemic necrosis and hypoxic state
(Kaur et al, 2004; Preusser et al 2006). In turn, hypoxia
stimulates pseudopalisading cells to activate hypoxia-
inducible factor (HIF-1α) leading to overexpression of
angiogenetic factors and peritumoral microvascular
proliferations (Brat et al., 2002, 2004). Hypoxia is also
responsible for the highly invasive behaviour of GBM,
as it elicits migration of GBM cells away from hypoxic
areas (Pennacchietti et al., 2003; Brat et al., 2004).
Pseudopalisading necrosis and microvascular
hyperplasia currently represent two of the most powerful
predictors of poor prognosis in human GBM (Rong et
al., 2006).
Tremendous technical advances have allowed the
use of Magnetic Resonance Imaging (MRI) as a non-
invasive method for detection and diagnosis of primary
brain tumors. In astrocytic tumors MRI also gives useful
prognostic indications, detecting the early formation of
pseudopalisading necrosis and microvascular
proliferations during the progression of secondary GBM
from lower grade tumor (Goldbrunner et al., 2000). MRI
also represents a fundamental tool for monitoring blood-
brain barrier permeability and the therapeutic
responsiveness of GBM in terms of tumor regression and
inhibition of angiogenesis (Zhu et al., 2000; Henson et
al., 2005).
Intriguing insights into the pathogenesis of GBM
and more accurate prognostic and therapeutic directions
are emerging from the contextual examination of
clinical, immunohistopathological and genomic features.
The study of the biological mechanisms underlying
GBM development and the evaluation of new therapies
require accurate and reproducible brain tumor animal
models. Predictable animal models of GBM should
recapitulate the main pathobiological hallmarks of the
human disease concerning progression, kinetics and
tumor-host interaction. Although rodent orthotopic
xenografts of human GBM are widely employed in
preclinical research, their use remains controversial and
these models have been criticized for not recapitulating
the main morphological and biological aspects of human
GBM (Fomchenko and Holland, 2006). In fact, recent
investigations confirmed that fundamental immuno-
histopathological, neuroimaging and biological
similarities exist between murine orthotopic xenograft
models and naturally occurring human GBM (Candolfi
et al., 2007; Martínez-Murillo and Martínez, 2007). A
detailed characterization and standardization are
therefore mandatory to rule out the predictivity range of
specific preclinical models.
In this study, we report the histopathological,
immunohistochemical and imaging (MRI) characte-
rization of mouse orthotopic xenograft models using two
different cell lines of human GBM, U251 and 
U87MG.
Material and methods
Cell lines
The human brain tumor cell lines U251 and U87MG
(glioblastomas) were purchased from National Cancer
Institute, Bethesda, MD and from American Type Cell
Culture, Manassas, VA respectively and grown in
RPMI1640 medium supplemented with 10% Fetal Calf
Serum (FCS), 2 mM L-Glutamine (U251) and Eagle's
Minimal Essential Medium (E-MEM) supplemented
with 10% FCS, 2 mM L-Glutamine and 1% non-
essential amino acids (U87MG).
Animals and study design
All procedures adopted for housing and handling the
animals were in strict compliance with EEC and Italian
Guidelines for Laboratory Animal Welfare.
Ten Balb/c nude male mice, aged 6-8 weeks, were
anesthetized and stereotactically implanted in the
putamen region with human GBM cell lines, 5 mice with
U87MG and 5 mice with U251 (105 cells in 2 µ l of
PBS).
By using the stereotactic X and Y axis controller,
bregma (interception between median sagittal and
anterior coronal sutures) and lambda (interception
between median sagittal and posterior coronal sutures)
were identified as point 0. The following coordinates [+
1 mm posterior and + 3 mm lateral (right)] were set in
the apparatus and the point of injection identified. With a
microdrill a small hole was made in the desired point.
Cells were aspirated with a Hamilton syringe just prior
to injection (a brief mix of cells before aspiration is
performed to avoid precipitation of cells). By pointing to
the hole, Z axis was fixed to 0 and the syringe gently
inserted into the brain until reaching the correct
coordinate (-3.5 mm depth). Cells were injected at the
speed of 1 µl every minute. The syringe was left for an
additional 5 minutes in the hole before removing it to
avoid cell aspiration. The hole was closed using bone
wax and the wound was closed with sterile autoclips.
Following surgery, mice were monitored for recovery
until complete wakening.
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MR imaging
MRI was performed to visualize and delineate
tumors in the nuclei area. In order to monitor tumor
progression in each animal, a serial study was perfomed
by weekly imaging sessions starting at day 8 after
intracranial injection. For imaging studies, mice were
anesthetized with gas isofluoran, positioned prone in the
animal bed and inserted in the radiofrequency coil (38
mm i.d.) inside the magnet. Images were acquired on a
Bruker Pharmascan instrument (Bruker, Germany)
equipped with a 7.0 T horizontal magnet. Transversal
and sagittal spin echo multislice images were acquired as
pilot scans for correct localization of brain areas. Then,
T2-weighted (T2-W) and T1-weighted (T1-W) scans
were run in both transversal and coronal orientations in
order to better highlight the characteristics and location
of tumors. T1-W images were acquired before and after
iv injection of the contrast agent gadolinium-
diethylenetriamine penta-acetic acid (Gd-DTPA,
Guerbet). Imaging parameters were as follows:
T2-W: RARE (TR=5000 ms; TEeff=57 ms; rare
factor=8; 4 averages; FOV=2.5*2.5 cm2; Slice
thickness=1 mm; matrix=256*128; Total acquisition
time=5 min 20sec.
T1-W: RARE (TR=800 ms; TEeff=25.5 ms; rare
factor=4; 4 averages; FOV=2.5*2.5 cm2; Slice
thickness=1 mm; matrix=256*128; Total acquisition
time=1 min 42sec.
The whole imaging session lasted around 25 minutes
for each animal.
Histopathology & Immunohistochemistry
For histopathology and immunohistochemistry
studies, mice were sacrificed at a late stage of the
disease corresponding more or less to day 30 after
intracranial injection. The whole cranium from each
animal was collected and fixed in buffered formalin for 4
to 5 hours then decalcified in 5% formic acid diluted in
buffered formalin for 24h. The region between external
auditory meatus and orbit was sliced and a coronal
section of the whole cranium was obtained and
embedded in paraffin. Serial 4 µm-thick sections were
subsequently placed on Superfrost plus slides and
stained with haematoxylin and eosin (HE) for
histological examination. For immunohistochemistry,
sections were deparaffinized in xylene, rehydrated in
graded ethanol, and transferred to PBS. Heat treatment
antigen retrieval was performed in citrate buffer pH 6
(Vector). The slides were rinsed with PBS and
endogenous peroxidase was blocked using 3% hydrogen
peroxide (Sigma) in PBS for 10 minutes. The tissues
were incubated for 20 minutes at room temperature with
a protein-blocking solution consisting of PBS containing
0.05% Tween 20 (DAKO) and 10% normal goat serum
(Vector). Slices were then incubated with the primary
antibodies as reported in Table 1. The samples were then
rinsed in PBS containing 0,05% Tween 20 and incubated
for 30 minutes at room temperature with the appropriate
secondary antibody as reported in Table 1. Glial
fibrillary acidic protein (GFAP), S100 and Factor VIII
(FVIII)-stained slides were additionally incubated for 30
minutes at room temperature with streptavidin-
peroxidase (Dako). Finally, the reaction was developed
with diaminobenzidine (Dako).
Immunostained and HE-stained sections from each
case were qualitatively and quantitatively/semi-
quantitatively scored as follow (see also Table 2).
Necrosis (HE stained sections):
(-) = no intratumoral necrotic foci
(+) = <20% of the mass effaced by intratumoral
necrotic foci
(++) = 20-50% of the mass effaced by intratumoral
necrotic foci
(+++) = >50% of the mass effaced by intratumoral
necrotic foci
HIF-1α nuclear expression by neoplastic cells:
(-) = No immunohistochemical expression of HIF-
1α by neoplastic cells
(+) = Immunohistochemical expression of HIF-1α
by neoplastic cells in perinecrotic areas
(++) = Immunohistochemical expression of HIF-1α
by neoplastic cells in perinecrotic areas and in the viable
portion of the tumor as well
Tumor-associated thrombi:
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Table 1. Antibodies used in immunohistochemical assay: source, clone/company code, dilution, incubation time and secondary antibody.
ANTIBODY COMPANY CLONE / WORKING INCUBATION SECONDARY
COMPANY CODE DILUTION TIME ANTIBODY
Vimentin Epitomics SP20 1:50 40 min at 37°C EnVision Rabbit-HRP
GFAP Dako Z334 1:10000 40 min at 37°C Biotinylate Anti-Rabbit
S100 Dako Z311 1:15000 40 min at 37°C Biotinylated Anti-Rabbit
Synaptophysin Epitomics EP1098Y 1:100 1 hour at room temperature EnVision Rabbit-HRP
HLA-abc MBL EMR8-5 1:100 1 hour at room temperature EnVision Mouse-HRP
FVIII Dako N1505 1:80 40 min at 37°C Biotinylated Anti-Rabbit
Active-caspase-3 Cell Signaling Asp175 1:100 1 hour at room temperature EnVision Rabbit-HRP
p53 Dako DO-7 1:50 1 hour at room temperature EnVision Mouse-HRP
HIF 1α BD Transduction Laboratories 54 1:50 1 hour at room temperature EnVision Mouse-HRP
Ki-67 Dako MIB-1 1:150 1 hour at room temperature EnVision Mouse-HRP
AKT (pS473) Epitomics EP 2109y 1:200 1 hour at room temperature EnVision Rabbit-HRP
(-) = no FVIII positive intratumoral thrombi
(+) = <20 FVIII positive intratumoral thrombi
(++) = 20-50 FVIII positive intratumoral thrombi
(+++) = >50 FVIII positive intratumoral thrombi
Tumor angiogenesis (microvessel density):
The number of FVIII positive vascular channels
were assessed in four 400x microscopic fields both in
the centre and at periphery of the tumor. Mean values
from each case are reported (Table 2).
Ki-67 (MIB-1) and p53 expression by neoplastic
cells: Both for Ki-67 and p53, the number of
immunopositive nuclei were counted on a total amount
of about 3000 neoplastic cells at 200x microscopic
fields. Mean percentages from each case are reported
(Table 2).
Immunohistopathological evaluations were
performed using Image Pro-Plus 6.0 software
technology. Statistical analysis was performed using
Mann-Whitney test (Prism 3.0 software).
Results
Imaging
The development and growth of neoplastic lesions
derived from U251 or U87MG implantation were
followed in each animal at different time points. Both
cell lines grew very quickly, even if a more aggressive
growth pattern was noticed in the U251 model.
In terms of MR signal intensity, some differences
were observed for the two cell lines. The U251 tumor
was delineated from normal brain tissue as an isointense
or lightly hyperintense, poorly demarcated, irregularly
rounded area surrounded by a hyperintense rim
(peritumoral edema). The development of intratumoral
necrotic areas was common in this model (Fig. 1a'-d').
The U87MG tumor was delineated from normal brain
tissue as a hyperintense, well demarcated, nodular area,
with a regularly expansile growth (tennis ball
appearance) (Fig. 2a-d). In both models the compression
caused by tumor growth leads to internal hydrocephalus,
due to blockage of cerebrospinal fluid outflow in the
ventricles or in the subarachnoid space (Fig. 1d' and 2d).
Gd-DTPA uptake profile in U251 xenograft showed that
the tumor was poorly distinguishable in the pre-contrast
T1-weighted image (Fig. 3b) and it became gradually
hyperintense after iv contrast injection in the tail vein.
Irregular signal dishomogeneities were present inside the
tumor, due to the presence of necrotic areas. Contrast
agent, initially confined in the viable portion of the
tumor, gradually accumulated in necrotic regions and
diffused in the peritumoral well vascularized and
edematous areas (Fig. 3c,d).
Histopathology and immunohistochemistry
U251 orthotopic xenografts were morphologically
characterized by a single, densely cellular, irregular,
poorly demarcated, unencapsulated, intrahemispheric
mass with peripheral medusoid projections invading the
882
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Table 2. The table summarizes the scores for the different histopathological and immunohistochemical aspects investigated in U87MG and U251
murine orthotopic xenograft models of human glioblastoma multiforme.
GBM line Record Ki-67 p53* Angiogenesis* Necrosis HIF-1α Thrombi
Central Peripheral
U87MG #67-1 45.10% 11.61% 9 3.25 - - ++
#663-1 41.69% 24.11% 10.5 1.25 ++ + +++
#851-1 56.78% 11.94% 12 2.25 - - +
#861-1 41.71% 6.94% 9.25 3 + + ++
#899-1 32.85% 9.8% 14.5 2.25 - - +++
Mean 43.63% 12.88% 11.05 2.4
U251 #389-1 36.71% 90.12% 0 6.25 ++ ++ -
#952-2 47.74% 99.8% 0 7.5 + ++ -
#966-3 51.48% 99.72% 0.25 10.5 ++ ++ -
#9614-3 63.66% 95.43% 0 7.5 + ++ -
#9615-3 60.35% 97.51% 2 11 + ++ -
Mean 52% 96.51% 0.45 8.55
* Statistically significant differences between U251 and U87MG group. Necrosis (HE stained sections): (-) = no intratumoral necrotic foci, (+) = <20% of
the mass effaced by intratumoral necrotic foci, (++) = 20-50% of the mass effaced by intratumoral necrotic foci, (+++) = >50% of the mass effaced by
intratumoral necrotic foci; HIF-1α nuclear expression by neoplastic cells: (-) = No immunohistochemical expression of HIF-1α by neoplastic cells, (+) =
Immunohistochemical expression of HIF-1α by neoplastic cells in perinecrotic areas, (++) = Immunohistochemical expression of HIF-1α by neoplastic
cells in perinecrotic areas and in the viable portion of the tumor as well; Tumor-associated thrombi: (-) = no FVIII positive intratumoral thrombi, (+) = <20
FVIII positive intratumoral thrombi, (++) = 20-50 FVIII positive intratumoral thrombi, (+++) = >50 FVIII positive intratumoral thrombi; Tumor angiogenesis
(microvessel density): The number of FVIII positive vascular channels were assessed in four 400x microscopic fields both in the centre and at periphery
of the tumor. Mean values from each case are reported; Ki-67 and p53 expression by neoplastic cells: Both for Ki-67 and p53. the number of
immunopositive nuclei were counted on a total amount of about 3000 neoplastic cells at 200x microscopic fields. Mean percentages from each case are
reported.
surrounding cerebral parenchyma and often spreading
into the controlateral hemisphere. This mass consisted of
tightly packed, interlacing bundles of pleomorphic,
spindle to stellate cells with occasional giant and
multinucleated elements. Findings of atypia, including
marked anisocytosis, anysokariosis, bizarre mitosis and
multiple irregular nucleoli, were common among
neoplastic cells. In all examined cases, wide intratumoral
foci of vascular-oriented (serpentine) pseudopalisading
necrosis were observed (Table 2; Fig. 4A). Infiltrating
neoplastic projections at the periphery of the mass were
intimately associated with tortuous microvascular
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Fig. 1. T2-weighted images: coronal sections at different time points showing the progression and growth of the intrahemispheric neoplastic lesions in
U251 (a': day 8; b': day 15; c': day 21; d': day 28). U251 xenograft appears as an isointense or lightly hyperintense, poorly demarcated, irregularly
rounded area surrounded by a hyperintense rim (peritumoral edema, asterisks). Note also the presence of intratumoral necrosis (arrow).
proliferations often characterized by hypertrophic lining
endothelium. Prominent rarefaction-status spongiosus
and edema of the surrounding neuroparenchyma and
occasional intratumoral and peritumoral haemorrhagic
foci were also observed. Infiltrating neoplastic
extensions along the ependimal surface into the lateral
ventricles (Fig. 4B) as well as along the pial surface into
the subarachnoid space represented a common finding.
In U251 orthotopic xenografts, almost all the
neoplastic cells displayed intense vimentin expression,
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Fig. 2. T2-weighted images: coronal sections at different time points showing the progression and growth of the intrahemispheric neoplastic lesions in
U87MG xenografts (a: day 8, b: day 14, c: day 22, d: day 29). U87MG xenograft appears as a hyperintense, well demarcated, nodular area, with a
regularly expansile growth and a tennis ball appearance (arrowhead).
whereas only 40% and 10% of these cells resulted GFAP
and S100 positive respectively (Fig. 4C). GFAP-
expression was also observed in the loose and
incomplete rim of reactive astrogliosis that surrounded
neoplastic structures (Fig. 4C). A diffuse synaptophysin
expression was observed in bearing brain parenchyma
but not in U251 neoplastic cells. An accurate distinction
between U251 neoplastic astrocytes and murine reactive
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Fig. 3. MR images of a mouse intracranially injected with U251 cell line (day 28). A T2-weighted image (a) is compared with T1-weighted images before
(b) and after (c, d) contrast agent injection (c, d: 12' and 30' after Gd-DTPA iv injection). U251 tumor is poorly distinguishable in the pre-contrast T1-
weighted image and it becomes gradually hyperintense after iv contrast injection. Contrast agent, initially confined in the viable portion of the tumor
(asterisks), gradually accumulates in necrotic regions (arrow) and diffuses in the peritumoral well vascularized and edematous areas (arrowheads).
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Fig. 4. Histopathology and immunohistochemistry of murine intracranial orthotopic xenograft of glioblastoma multiforme using U251 human cell line. A.
Linear intratumoral area of pseudopalisading necrosis. HE staining. B. The human-specific marker HLA-abc defines the infiltrative projections of
intracranial U251 xenograft with invasion of lateral ventricles and spread toward the controlateral hemisphere. HLA-abc immunostaining. 
C. Approximately 40% of the neoplastic cells within the U251 xenograft display GFAP expression. Marked GFAP expression is also evident in the
incomplete and loose peripheral rim of astrogliosis. GFAP immunostaining. D. Disseminated along the infiltrative medusoid neoplastic projections are
numerous FVIII-positive vascular channels. FVIII immunostaining. E. Disseminated along the serpiginous intratumoral pseudopalisading necrosis are
numerous apoptotic cells. Active caspase-3 immunostaining. F. Virtually all neoplastic cells within the U251 xenograft display prominent intranulcear
accumulation of p53 protein. p53 immunostaining. G. Numerous neoplastic cells with prominent HIF-1α-nuclear expression are concentrated along an
intratumoral area of pseudopalisading necrosis. HIF-1α immunostaining. Scale bar: A, C-G, 100 µm; B, 250 µm.
 
astrocytes and gemistocytes was performed using the
human-specific marker HLA (human leukocyte antigen)-
abc. In addition, HLA-abc staining clearly underlined
the infiltrative intrahemispheric growth of U251
xenografts (Fig. 4B). FVIII-staining confirmed the florid
angiogenetic processes (high microvessel density)
associated with the peripherally infiltrating neoplastic
projections (Table 2; Fig. 4D). Only occasional FVIII-
positive intratumoral vascular channels were observed in
U251 orthotopic xenografts (Table 2). Multifocal groups
of active caspase-3-positive apoptotic cells, mostly
concentrated in the necrotic and perinecrotic areas, were
observed (Fig. 4E ). Scattered apoptotic cells were also
found in the viable neoplastic portions. Almost the entire
U251 neoplastic cell population (96,51%) displayed a
prominent nuclear accumulation of p53 protein (Table 2;
Fig. 4F). Fifty-two % of U251 neoplastic cells also
showed nuclear Ki-67 expression (Table 2). Multifocal
HIF-1α nuclear expression by U251 neoplastic cells was
recorded within pseudopalisades along the perinecrotic
areas, as well as in the surrounding viable portion of the
tumor (Table 2; Fig. 4G). For the vast majority of U251
neoplastic cells, pAkt-immunohistochemical analysis
revealed a diffuse, finely granular positivity both in the
cytoplasm and along the cell membrane (Fig. 
6A).
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Fig. 5. Histopathology and immunohistochemistry of murine intracranial orthotopic xenograft of glioblastoma multiforme using U87MG human cell line.
A. U87MG xenograft appears as well-demarcated intrahemispheric expansile mass consisting of tightly packed sheets of round to polygonal,
occasionally plump spindle cells with abundant intensely eosinophilic cytoplasm. HE staining. B. U87MG xenograft result GFAP-negative and it is
rimmed by a prominent GFAP-positive capsular reaction of astrogliosis. GFAP immunostaining. C. The human-specific marker HLA-abc highlights the
intrahemispheric expansile growth of U87MG xenograft. HLA-abc immunostaining. D. The widespread intratumoral network of anastomosing vascular
lacunae show an incomplete FVIII-positive endothelial lining. Furthermore, FVIII-staining highligts a large number of non-occlusive vascular
microthrombi. FVIII immunostaining. Scale bar: 100 µm.
 
U87MG orthotopic xenografts were morphologically
characterized by a single, densely cellular, well
demarcated, non-infiltrating, expansile, intrahemispheric
nodular mass surrounded by a compact reaction of
astrogliosis. The mass consisted of tightly packed sheets
of plump, round to polygonal, occasionally spindle cells
with abundant intensely eosinophilic cytoplasm and
frequent giant and multinucleated elements (Fig. 5A).
Moderate findings of atypia were observed among
neoplastic cell. These included anisocytosis,
anysokariosis, bizarre mitosis and multiple irregular
nucleoli. Variable-sized intratumoral foci of coagulative
necrosis were observed in only two cases (Table 2).
These were associated with prominent vascular
thrombosis and concurrent marked neutrophilic
infiltration. Neoplastic sheets were often separated by
delicate anastomosing vascular lacunae and variable
degrees of edema. Occasional intratumoral and
peritumoral haemorrhagic foci were also observed.
In U87MG orthotopic xenografts, almost all the
neoplastic cells displayed intense vimentin expression.
On the contrary, no concurrent GFAP or S100 expression
was recorded. Striking GFAP-expression was observed
in the compact rim of reactive astrogliosis that
surrounded neoplastic structures (Fig. 5B). A diffuse
synaptophysin expression was observed in bearing brain
parenchyma but not in U87MG neoplastic cells. Also, in
these cases, the use of the human-specific marker HLA-
abc allowed an accurate distinction between U87MG
neoplastic astrocytes and murine reactive
astrocytes/gemistocytes. In addition, human-specific
HLA-abc antibody staining clearly underlined the
expansile intrahemispheric growth of U87MG
xenografts (Fig. 5C). FVIII-staining confirmed the
presence of a high intratumoral microvessel density,
consisting of a widespread network of anastomosing
vascular lacunae. Furthermore, FVIII-staining delineated
a large number of non-occlusive vascular microthrombi
(Table 2; Fig. 5D). Only occasional FVIII-positive
peritumoral vascular channels were observed in U87MG
orthotopic xenografts (Table 2). Numerous groups of
active caspase-3-positive apoptotic cells, mostly
concentrated in the occasional necrotic and perinecrotic
areas, were observed. Scattered apoptotic cells were also
found in the viable neoplastic portions. Only 12,88% of
the U87MG neoplastic cell population displayed variable
degrees of p53-nuclear expression (Table 2). About 44%
of U87MG cells showed nuclear Ki-67 expression
(Table 2). HIF-1α nuclear expression by U87MG
neoplastic cells was mostly distributed along the
occasional perinecrotic areas (Table 2). For the vast
majority of U87MG cells, pAkt immunohistochemical
analysis revealed a diffuse, finely granular positivity,
both in the cytoplasm and along the cell membrane (Fig.
6B).
Statistical analyses revealed significant differences
between U251 and U87MG groups with respect to the
peripheral (p=0,0079) and the central (p=0,0079)
microvessel density (FVIII-immunostaining; Table 2). A
significant difference between the two groups was also
observed for p53- (p=0,0001) but not for Ki-67-
immunopositive cells (p=0,2) (Table 2).
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Fig. 6. Murine intracranial xenograft models of glioblastoma multiforme using U251 and U87MG human cell lines. Both U251 (A) and U87MG (B) tumor
cells show diffuse, finely granular positivity for pAkt within the cytoplasm and along the cell membrane. pAkt immunostaining. Scale bar: 100 µm.
Discussion
In this study, the histopathological, immuno-
histochemical and MRI characterization highlighted
profound differences between the two investigated
orthotopic xenograft models of GBM. Indeed, where the
U251 orthotopic xenograft model recapitulates most of
the salient pathobiological features described in human
spontaneous GBM, the U87MG orthotopic xenograft
model proved to be very different.
MR imaging monitoring of U251 orthotopic
xenografts was able to detect the progressive invasive
growth into the surrounding brain parenchyma, the
development of intratumoral necrotic areas, as well as
the peripheral florid vascular activity with edema.
Similar imaging findings are also reported for human
GBM, and are considered important diagnostic and
prognostic features (Rong et al., 2006). In U251
xenografts, the nature of signal alterations observed on
MRI was then confirmed through the histopathological
and immunohistochemical examination.
Neoplastic cells in U251 orthotopic xenografts
showed a typical GBM phenotype, staining concurrently
positive for vimentin, GFAP, S100 and negative for
synaptophysin (Kleihues et al., 2000; Porter et al., 2004).
In agreement with the striking interhemispheric invasive
spread reported for human spontaneous GBM, in this
study, HLA-abc staining precisely defined the prominent
infiltrative behaviour of the growing U251 xenograft and
its tendency to invade the ventricular system (Kleihues
et al., 2000).
In U251 orthotopic xenografts, intratumoral areas of
coagulative necrosis, similar to that described for human
spontaneous GBM, displayed a serpiginous morphology
and were peculiarly lined by pseudopalisading neoplastic
cells. The coagulative nature and the serpiginous
morphology of the necrotic areas suggest an underlying
vascular damage with ischemic process (Zagzag et al.,
2000a; Brat et al., 2004). In human GBM, the activation
of a prothrombotic state along neoplastic vasculature is
considered one of the most likely causes of ischemic
necrosis. However, the molecular mechanisms
promoting this peculiar event are largely unclear (Brat
and Van Meir, 2004). In U251 xenografts neither
histopathological examination or FVIII-staining were
able to detect necrosis-associated occlusive thrombotic
lesions. This finding indicates that vascular thrombosis
does not represent the mechanisms leading to
pseudopalisading necrosis in this model. However, other
mechanisms such as vascular collapse and marked
CD95-CD95 ligand-mediated apoptotic activity should
be considered in the pathogenesis of GBM
pseudopalisading necrosis (Tachibana et al., 1996;
Kleihues et al., 2000; Brat and Van Meir, 2004). In U251
orthotopic xenografts, a prominent active caspase-3
signal was indeed observed along pseudopalisades and
within the cellular debris in necrotic areas. A similar
immunohistochemical distribution of active caspase-3
has been described in human spontaneous GBM as well
as in murine subcutaneous xenografts using U251 cell
line (Ray et al., 2002; Gdynia et al., 2007). These
findings may indicate that not only in human GBM but
also in U251 xenograft models, the apoptotic pathway
plays a remarkable role in the formation of
pseudopalisading necrosis. In addition, recent in vitro
and in vivo observations indicated that in glioblastoma
cells, constitutive caspase-3 activity promotes migration
and invasiveness in a CD95/CD95 ligand independent
manner (Gdynia et al., 2007). U251 intracranial model
could be therefore proposed as a reasonable preclinical
tool to test the efficacy of caspase-3 inhibition as a novel
strategy for the treatment of glioblastomas.
In U251 orthotopic xenografts, the pattern of
angiogenesis was characterized by florid microvascular
proliferations along the neoplastic infiltrative
projections. This latter finding represents a common
feature in naturally occurring human GBM (Homma et
al., 2006). In these xenografts, pseudopalisading
necrosis, microvascular proliferations and neoplastic
invasion of the adjacent brain parenchyma represent
strictly interconnected features (Brat and Van Meir,
2004). Furthermore, as reported for most of the human
spontaneous GBM, these features are associated with
widespread HIF-1α expression along pseudopalisades,
as well as in the viable portion of the tumor (Zagzag et
al., 2000b, 2006). Taken together, these aspects suggest
that human spontaneous GBM and this model share the
same unique pathophysiological mechanisms that link
necrosis and hypoxia to microvascular proliferations and
invasive behaviour (Rong et al, 2006). For this reason,
the U251 orthotopic mouse model could be efficaciously
employed in the study of compounds that target HIF-1α
downstream signalling pathway.
TP53 is known to be mutated in most of the
secondary human GBM and also in lower grade
precursor astrocytic tumors. Furthermore, immuno-
histochemical examination demonstrated that mutation
of TP53 in secondary GBM generally leads to a
nonfunctional p53 protein accumulation within nuclei of
neoplastic cells (Kleihues et al., 2000; Ganigi et al.,
2005; Brat et al., 2007). The same pattern of expression
was observed for the U251 orthotopic xenograft model,
where p53 immunostaining revealed a marked nuclear
staining in almost the entire neoplastic cell population.
The U251 cell line is known to harbour mutated TP53
(Lang et al., 1998). Several studies have demonstrated
that GBM harbouring TP53 mutation and non fuctional
p53 may exhibit a specific spectrum of susceptibility to
adjuvant therapy and different postsurgical outcomes
(Lang et al., 1998; Matsumoto, 1998; Shih et al., 2005).
For the reasons mentioned above, the U251 orthotopic
mouse model could be proposed as a reasonable
preclinical tool to test the efficacy of novel adjuvant
therapy protocols designed for TP53-mutated GBM.
For the vast majority of the examined features, the
U87MG orthotopic xenograft model proved to be very
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dissimilar from both the U251 orthotopic xenograft
model and human spontaneous GBM. MR imaging
monitoring of U87MG xenografts detected a
progressively expansile, non-infiltrating regularly
growing mass (tennis ball appearance) without
consistent evidence of intratumoral necrosis,
microvascular proliferation and invasiveness. All these
aspects were then confirmed through the histo-
pathological and immunohistochemical examination of
serial coronal sections of the whole cranium. U87MG
orthotopic xenograft cells showed a vimentin-positive,
GFAP and S100-negative phenotype that barely fits with
spontaneous GBM phenotype (Kleihues et al., 2000;
Porter et al., 2004). Another unusual finding in
spontaneous human GBM, but always detected in
U87MG xenografts, is represented by a complete and
well-organized GFAP positive astroglial capsular
reaction, limiting tumor growth and extension into the
surrounding brain parenchyma.
In U87MG orthotopic xenografts the pattern of
angiogenesis, characterized by a delicate intratumoral
network of anastomosing vascular lacunae, is completely
different when compared to the florid microvascular
proliferations described in the U251 orthotopic model
and in spontaneous human GBM. Although numerous
fibrin thrombi were observed lodging in the vascular
lacunae of U87MG orthotopic xenografts, occlusive
events with consequent ischemic phenomena were
uncommon. Unlike U251 xenografts, necrotic areas in
U87MG model did not display the peculiar
pseudopalisading morphology, and they were not
associated with any other findings typical of high grade
astrocytic tumor, such as pheripheral microvascular
proliferation and invasive behaviour (Rong et al., 2006).
Necrosis was also accompanied by a concurrent marked
neutrophilic infiltration that represents an uncommon
feature in spontaneous human GBM (Rong et al., 2006).
For the reasons mentioned above, necrosis in U87MG
xenografts should be considered an incidental finding,
lacking any pathobiological analogies with necrotic
lesions in spontaneous human GBM.
In U87MG xenografts, HIF-1α expression was
observed in perinecrotic neoplastic cells. This pattern of
distribution is quite similar to that reported for human
GBM (Rong et al., 2006). However, the non-palisading
morphology, as well as the inconsistency of the
intratumoral necrosis in U87MG xenografts, make the
pathobiological value of this finding not comparable
with the human counterpart.
U87MG cells are known to be TP53 wild type (Lang
et al., 1998; Clark et al., 2007; Trog et al., 2007). This
aspect was also confirmed in this study, where U87MG
orthotopic xenografts exhibited a typical p53 wild type
immunhistochemical pattern with only 13% of
neoplastic cells showing different intensity of
expression.
Although it is still a matter for debate, several
studies have demonstrated that in spontaneous GBM, Ki-
67 expression is directly correlated with aggressive
behaviour and poor prognosis (Torp, 2002;
Kleinschmidt-DeMasters et al., 2006). In this study, both
the orthotopic models examined exhibited elevated
levels of Ki-67 expression and no significant differences
were observed.
As expected for both cell lines studied, orthotopic
xenografts displayed a diffuse pAkt-expression (Zinda et
al., 2001; de la Peña et al., 2006; Zhang et al., 2007). In
GBM, EGFR overexpression-amplification and PTEN
mutation represent the two major genetic abnormalities
accounting for the constitutive activation of PI3K/Akt
signalling pathway. These events result in cell
proliferation, increased cell survival and resistance to
radiation (Pelloski et al., 2006). For this reason, for both
the GBM xenograft models investigated, immuno-
histochemical monitoring of pAkt-expression may
represent a useful tool in preclinical studies of
compounds specifically targeting EGFR overexpression-
amplification and PTEN mutation.
In conclusion, this study demonstrates that the U251
orthotopic xenograft mouse model may be proposed as a
predictive and reliable tool to target human GBM in
preclinical studies, since it recapitulates most of the
salient pathobiological features reported for human
spontaneous GBM.
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